Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19830971 | 1.00 | NAAA (0.40) | NAAACYP2C19CHRM2CHRM4CHRM1 | |
| SCHEMBL28208008 | 0.87 | NAAA (0.49) | NAAACYP2C19EPHX1HTTSCN9A | |
| SCHEMBL27858518 | 0.86 | CYP2C19 (0.40) | NAAACYP2C19EPHX1HTTSCN9A | |
| SCHEMBL8052216 | 0.85 | CYP2C19 (0.39) | NAAACYP2C19EPHX1HTTSCN9A | |
| SCHEMBL6334628 | 0.83 | CYP2C19 (0.38) | NAAACYP2C19EPHX1HTTSCN9A | |
| SCHEMBL6327829 | 0.83 | MGAM (0.44) | NAAACYP2C19EPHX1SCN9AKMT2A | |
| SCHEMBL31412819 | 0.83 | MGAM (0.44) | NAAACYP2C19EPHX1SCN9AKMT2A | |
| SCHEMBL17987658 | 0.83 | CYP2C19 (0.56) | NAAACYP2C19CHRM2CHRM4CHRM1 | |
| Acetic Acid SCHEMBL27875197 | 0.82 | CYP2C19 (0.37) | NAAACYP2C19HTTSCN9ASMN1; SMN2 | |
| SCHEMBL28077322 | 0.81 | NAAA (0.39) | NAAACYP2C19CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11752078-B2 | Oil-in-water emulsions containing 4-hydroxyacetophenone and anionic emulsifiers | SYMRISE AG (DE) | 2023-09-12 | — | — | US | disclosed |
| EP-2723312-B2 | TAPIOCA STARCH IN COSMETIC PREPARATIONS CONTAINING SILICONE ELASTOMER | BEIERSDORF AG (DE) | 2020-03-18 | — | — | EP | disclosed |
| EP-2364688-B1 | Cosmetic preparations with highly elastic texture | BEIERSDORF AG (DE) | 2019-07-24 | — | — | EP | disclosed |
| US-20180243189-A1 | Oil-in-Water Emulsions Containing 4-Hydroxyacetophenone and Anionic Emulsifiers | SYMRISE AG (DE) | 2018-08-30 | — | — | US | disclosed |
| EP-3122316-B1 | OIL-IN-WATER EMULSIONS CONTAINING 4-HYDROXYACETOPHENONE AND ANIONIC EMULSIFIERS | SYMRISE AG (DE) | 2018-06-27 | — | — | EP | disclosed |
| EP-3275962-A1 | METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME | Takasago International Corporation (JP) | 2018-01-31 | — | — | EP | disclosed |
| EP-2723312-B1 | TAPIOCA STARCH IN COSMETIC PREPARATIONS CONTAINING SILICONE ELASTOMER | BEIERSDORF AG (DE) | 2017-10-04 | — | — | EP | disclosed |
| EP-2549976-B1 | SKIN-FRIENDLY ACTIVE INGREDIENT COMBINATION TO COMBAT ACNE | BEIERSDORF AG (DE) | 2016-11-23 | — | — | EP | disclosed |
| EP-2773310-A1 | COSMETIC PREPARATION COMPRISING PULVERISED SUBSTANCES FOR IMPROVING PERFUME ADHESION | Beiersdorf AG (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-2717970-A2 | POLYETHYLENE GLYCOL-FREE COSMETIC OR DERMATOLOGICAL PREPARATIONS | Beiersdorf AG (DE) | 2014-04-16 | — | — | EP | disclosed |
| EP-2717968-A2 | COSMETIC AND DERMATOLOGICAL EMULSION PREPARATIONS WITH IMPROVED PERFUME RELEASE | Beiersdorf AG (DE) | 2014-04-16 | — | — | EP | disclosed |
| EP-2627414-A2 | MICROBIOLOGICALLY STABLE, EASILY APPLICABLE PREPARATIONS COMPRISING ACTIVE SUBSTANCES SUSCEPTIBLE TO DEGRADATION | Beiersdorf AG (DE) | 2013-08-21 | — | — | EP | disclosed |
| US-20130158130-A1 | POLYMER COMBINATIONS FOR COSMETIC PREPARATIONS | BEIERSDORF AG (DE) | 2013-06-20 | — | — | US | disclosed |
| WO-2013064609-A1 | COSMETIC PREPARATION COMPRISING PULVERISED SUBSTANCES FOR IMPROVING PERFUME ADHESION | BEIERSDORF AG (DE) | 2013-05-10 | — | — | WO | disclosed |
| WO-2012167905-A2 | POLYETHYLENE GLYCOL-FREE COSMETIC OR DERMATOLOGICAL PREPARATIONS | BEIERSDORF AG (DE) | 2012-12-13 | — | — | WO | disclosed |
| WO-2012167900-A2 | COSMETIC AND DERMATOLOGICAL EMULSION PREPARATIONS WITH IMPROVED PERFUME RELEASE | BEIERSDORF AG (DE) | 2012-12-13 | — | — | WO | disclosed |
| WO-2011124244-A2 | MICROBIOLOGICALLY STABLE, EASILY APPLICABLE PREPARATIONS COMPRISING ACTIVE SUBSTANCES SUSCEPTIBLE TO DEGRADATION | BEIERSDORF AG (DE) | 2011-10-13 | — | — | WO | disclosed |
| EP-2364688-A2 | Cosmetic preparations with highly elastic texture | Beiersdorf AG (DE) | 2011-09-14 | — | — | EP | disclosed |
| EP-2221045-A1 | Skin care formulations with an immediate tautening effect | Beiersdorf AG (DE) | 2010-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11752078-B2 | Oil-in-water emulsions containing 4-hydroxyacetophenone and anionic emulsifiers | HSD17B10, GNPAT, HSD17B4 | NAAA 1049/4885CYP2C19 143/4885CHRM2 2787/4885 |
| US-20180243189-A1 | Oil-in-Water Emulsions Containing 4-Hydroxyacetophenone and Anionic Emulsifiers | HSD17B10, GNPAT, HSD17B4 | NAAA 1049/4885CYP2C19 143/4885CHRM2 2787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.